Table 3.
Clinico-Pathological Detail and Follow-Up of All L-PSDs
| Case | Sex/Age | Symptom | Size (cm) | Location to Ampulla | Mitotic Count | Risk | Adjuvant Imatinib | OS | |
|---|---|---|---|---|---|---|---|---|---|
| Opposite | Sup./Inf. | ||||||||
| 1 | F/63 | GI Bleeding | 1.6 | Yes | Superior | 5/50HPF | Very low | No | 53.1 months |
| 2 | M/59 | GI Bleeding | 3.0 | Yes | Inferior | 8/50HPF | High | Yes | 50.8 months |
| 3 | F/71 | Pain | 2.0 | Yes | Superior | 2/50HPF | Very Low | No | 44.6 months |
| 4 | M/46 | Pain | 3.3 | Yes | Superior | 1/50HPF | Low | No | 30.3 months |
| 5 | F/50 | Pain | 4.0 | Yes | Inferior | 1/50HPF | Low | No | 24.2 months |
| 6 | M/66 | Asymptomatic | 4.0 | Yes | Inferior | 1/50HPF | Low | No | 25.3 months |
| 7 | F/65 | GI Bleeding | 2.5 | Yes | Superior | 2/50HPF | Low | No | 14.9 months |
| 8 | F/44 | Pain | 4.6 | Yes | Inferior | 4/50HPF | Low | No | 14.5 months |
| 9 | M/61 | GI Bleeding | 3 | Yes | Inferior | 4/50HPF | Low | No | 14.0 months |